Biophage Pharma Inc. Announces New Development Breakthrough In Its PDS(R) Biosensors technology

Biophage Pharma Inc. (TSX.V: BUG) today announced a new development in its PDS(R) Biosensor technology. The Biosensor unit is now able to detect toxins. This is the first step towards a new application of the PDS(R) Biosensor technology in the field of toxicity testing, as an alternative to animal testing.